# Johnson & Johnson (JNJ) — Q2-2025 Earnings Results

**Report date:** 2025-07-16 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2025

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Up 6.19%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.77 | N/A | +4.53% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting ongoing efforts in innovation. They emphasized a commitment to operational efficiency moving forward.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on innovation and maintaining strong operational efficiency.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report indicates that Johnson & Johnson is performing well in terms of earnings per share, which exceeded expectations. The stock rose by 6.19% following the announcement, reflecting investor confidence in the company's ability to generate profits. However, the lack of revenue figures and guidance leaves some uncertainty about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2025_